BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2010
View Archived Issues
GSK-1362885 is safe in healthy volunteers and patients with type 2 diabetes
Read More
REGN-88 well tolerated and reduces inflammation in phase I trials
Read More
Portland State University and DesignMedix claim new antimalarials
Read More
ArQule describes new RAF kinase inhibitors
Read More
Abbott identifies new kinase inhibitors
Read More
Palatin Technologies claims new melanocortin receptor ligands
Read More
SOX-9 implicated in chronic pancreatitis
Read More
MCP-1 is a potential biomarker for atherosclerosis in obese subjects
Read More
CP-870893/gemcitabine combination is safe in pancreatic cancer
Read More
First-in-human data reported on anticancer agent PF-337210
Read More
Raptor begins enrollment in phase III DR Cysteamine trial in nephropathic cystinosis
Read More
Aeterna Zentaris and Almac to develop companion diagnostic for AEZS-108 cancer therapy
Read More
Chelsea initiates phase III trial of Northera
Read More
Upsher-Smith acquires Ikano's ITI-111 for management of acute repetitive seizures
Read More
MORAb-022 cleared to enter phase I in the Netherlands
Read More
Stallergenes reports persistent efficacy of Actair in second year of phase IIb/III trial
Read More
Quark Pharmaceuticals reports results for QPI-1007 in glaucoma model
Read More
First patient receives CRMD-001 in phase II trial
Read More
Pipeline overview presented for TapImmune
Read More
EpiCept submits NDA for Ceplene in AML to FDA, requests priority review
Read More
DepoMed's NDA filing for DM-1796 triggers milestone payment from Abbott
Read More
Radiprodil does not meet primary endpoint in phase II trial in diabetic peripheral neuropathic pain
Read More
Aestus to develop Astellas' FK-614 as ATx-08-001 for neuropathic pain
Read More
Sanofi-aventis signs agreement for acquisition of TargeGen
Read More
NeuroSearch claims new nicotinic acetylcholine receptor ligands
Read More
Chelsea provides update on phase II study of CH-4051
Read More
